Articles tagged with: Health
Op-Ed: Why mental health must become a political priority for Europe
15 May EU Institutions
Op-Ed: Why mental health must become a political priority for Europe
A holistic and collaborative approach will enable Europe to effectively begin tackling its mental health crisis, particularly among its youth.
Op-ed: Combatting unequal cancer treatment must remain part of the EU’s health agenda
08 Apr EU Institutions
Op-ed: Combatting unequal cancer treatment must remain part of the EU’s health agenda
As the European Parliament’s public health committee sets about its full legislative work, it must make cancer a top priority. It effects everyone equally and must be treated equally, too.
Op-ed: Why the EU must renew its commitment to global public health
18 Mar EU Institutions
Op-ed: Why the EU must renew its commitment to global public health
It is more important than ever that the EU leads on global health. Gavi for vaccines and the Global Fund for AIDS are not only charity, but a strategic imperative.
Op-ed: A critical medicine shortage calls for better EU collaboration
25 Feb EU Institutions
Op-ed: A critical medicine shortage calls for better EU collaboration
With the European Medicines Agency identifying shortages in more than 30 critical medicines, the single market presents an opportunity to rethink the EU’s approach to medicines.
Investing in healthy societies by boosting biotech competitiveness Partner Content
05 Nov Economics
Investing in healthy societies by boosting biotech competitiveness
Europe stands at a pivotal moment. To retain a competitive healthcare sector, the EU must move to promote innovation, strengthen its startup ecosystem, and attract global investment in R&D for strategic autonomy.
Beyond itching: Tackling Chronic Kidney Disease-associated Pruritus Partner Content
21 Oct
Beyond itching: Tackling Chronic Kidney Disease-associated Pruritus
Significant progress is being made in the fight against Chronic Kidney Disease-associated Pruritus but sustaining strong momentum is crucial to making a profound impact on patients’ lives, writes Sandra Ruckstuhl, Head of Corporate and External
Affairs, CSL Vifor
Meeting the challenge of rising European healthcare demand Partner Content
08 Oct
Meeting the challenge of rising European healthcare demand
Europe is facing a healthcare workforce crisis with an estimated 8 million job openings in health and care forecast to appear before 2031. In the first of a new series of articles looking at the challenges faced by Europe’s healthcare systems, The Parliament and AbbVie examine how to make better use of existing capacity by harnessing innovation and patient-centred care
Industrial policy and what it means for the healthcare sector Partner Content
05 Jul
Industrial policy and what it means for the healthcare sector
Putting a strong focus on competitiveness and industrial policy is a vital lesson Europe must learn from its recent challenges
Rare disease patients cannot be forgotten: a coordinated approach is needed Partner Content
22 May
Rare disease patients cannot be forgotten: a coordinated approach is needed
This HAE Day, Hilde Vautmans MEP makes the case for a European Action Plan for Rare Diseases to support Europe's rare disease patients
Championing change for rare disease patients in Europe: the case of hereditary angioedema Partner Content
16 May
Championing change for rare disease patients in Europe: the case of hereditary angioedema
The tobacco industry needs to explain itself better – starting with the European Ombudsman Partner Content
14 May
The tobacco industry needs to explain itself better – starting with the European Ombudsman
Despite ongoing efforts to inform regulators worldwide about tobacco harm reduction initiatives, misconceptions persist, particularly in Brussels. Increased engagement is needed to dispel outdated perceptions and ensure transparent dialogue ahead of the upcoming EU Tobacco Products Directive revision
Value-based healthcare systems and the need to address the unmet medical needs of patients with rare bleeding disorders Partner Content
17 Apr EU Institutions
Value-based healthcare systems and the need to address the unmet medical needs of patients with rare bleeding disorders
On World Haemophilia Day we sat down with MEP Elisabetta De Blasis and Sobi to discuss how value-based healthcare approaches can address the unmet needs faced by people living with rare bleeding disorders such as Haemophilia in an equitable manner
Bitter pills: Europe struggles with medicine shortages
11 Dec EU Institutions
Bitter pills: Europe struggles with medicine shortages
A fragile supply chain and increased demand are causing a shortfall in the EU’s stock of critical medicines. Gabriela Galindo looks at how policymakers can stabilise the situation
Antimicrobial resistance is the next global health challenge
08 Dec
Antimicrobial resistance is the next global health challenge
“The sooner we act, the more damage we can prevent in the future”, says MEP Nicu Stefanuta
On the ground in Moldova: how the country fights tuberculosis
07 Dec EU Institutions
On the ground in Moldova: how the country fights tuberculosis
The country continues to grapple with high tuberculosis rates, but joining the EU could help fight the disease, reports Julia Kaiser from Moldova, where she travelled with The Global Fund
Air pollution in Europe: The silent killer
06 Dec Energy & Environment
Air pollution in Europe: The silent killer
While pollution kills thousands of Europeans each year, the European Union is failing to meet the air quality targets set by the World Health Organisation, Marilyn Wright reports
Mental health in Europe: it is time for a strategy
05 Dec EU Institutions
Mental health in Europe: it is time for a strategy
In June, the Commission launched a Mental Health Communication. While this step is an admirable advancement, there is room for improvement, argues Dr. Alessandro Gallina from the European Public Health Alliance
Hi-tech health: How AI is revolutionising healthcare
04 Dec Technology
Hi-tech health: How AI is revolutionising healthcare
From faster diagnosis to new drug development, AI is driving exciting breakthroughs in medical services. But there are also calls for caution. Sarah Schug reports
Cardiomyopathies Matter: Time to tackle under-recognised cardiovascular diseases Partner Content
02 Dec
Cardiomyopathies Matter: Time to tackle under-recognised cardiovascular diseases
MEP Dr Juozas Olekas, together with experts participating in the Cardiomyopathies Matter initiative, Prof. Iacopo Olivotto and Dr Patricia Vlasman, call on EU and national decision-makers to recognise and address the substantial burden of cardiomyopathies on patients, families, healthcare systems and societies.
What Europe needs to achieve a sustainable blood ecosystem Partner Content
12 Oct
What Europe needs to achieve a sustainable blood ecosystem
As a new EU Regulation governing the field of Substances of human origins (SoHO) is being shaped, let’s look at the bigger picture, including factors that impact blood demand and opportunities to reduce the drain on the healthcare systems, says Antonis Kattamis, who is involved in the Blood and Beyond initiative
Animal experiments – how many times do we have to say enough is enough? Partner Content
06 Sep
Animal experiments – how many times do we have to say enough is enough?
For a record second time, citizens have overwhelmingly told the European Commission that they want an end to animal experiments in the EU.
Let’s make it right: A fit-for-purpose EU Paediatric Regulation can deliver for all children and adolescents with cancer Partner Content
01 Jul
Let’s make it right: A fit-for-purpose EU Paediatric Regulation can deliver for all children and adolescents with cancer
A political commitment to unleash the life-saving potential of the EU Pharmaceutical Strategy is needed say Gilles Vassal, Board Member of SIOP Europe, and Delphine Heenen, Committee Member of CCI Europe.
Unlocking the potential for rare disease therapies through wider collaborations between European Reference Networks and industry Partner Content
27 Jun
Unlocking the potential for rare disease therapies through wider collaborations between European Reference Networks and industry
Prominent MEPs seeking quicker wins for rare disease patients are backing closer collaboration between Europe’s reference networks and pharma companies through a novel multistakeholder initiative.
One Health: Healthy animals, healthier people, and a healthier planet Partner Content
23 Jun
One Health: Healthy animals, healthier people, and a healthier planet
Experts meeting at an event in Brussels discuss how AnimalHealthEurope‘s One Health strategy can succeed in achieving better health for both animals and people.